- Systems
- Consumables
- Point-of-Care Testing Devices
Asia Pacific Hemostasis Diagnostics Market size is valued at USD 748.2 million in 2022 and is poised to grow at a CAGR of 10.2% from 2023 to 2029. The global market provides a detailed overview of the market, and that can be segmented by product type, test type, by technology, and by end user. By product type, the market has been segmented into Systems, Consumables, and Point-of-Care Testing Devices. Point-of-Care Testing Devices segment is likely to be the largest and fastest-growing segment in terms of type. Based on test type, the Asia Pacific hemostasis diagnostics market is segmented into Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests. Among these, the Fibrinogen Test segment is growing at a significant rate in the global hemostasis diagnostic market during the forecast period 2022-2028. Based on technology, the Asia Pacific hemostasis diagnostics market is segmented into Optical, Mechanical, Electrochemical, and Others. The optical segment accounts for the largest share in 2021. Based on end-user, the segment has been segregated into Hospitals, Clinics, Diagnostic Laboratories, and Others (POC). The hospital segment is expected to dominate other segments in the market during the forecast period according to precision business insights. Hemostasis diagnostics devices help in the detection of hemostatic abnormalities such as excessive bleeding. Hemostasis is a body's normal reaction to an injury to reduce blood loss and repair the injury. The rise in the prevalence of several diseases such as cancer, diabetes, etc, population and lifestyle changes, the rise in the prevalence of hemophilia, and the increase in technological advancements are the major drivers in the Asia Pacific hemostasis market. Furthermore, increased awareness of hemostasis is also expected to boost the Asia Pacific diagnostics market.
Growing geriatric population, rise in prevalence of various diseases such as hemophilia are anticipated to propel the market growth over the forecast years. Moreover, the increasing technological advancement is also boosting the Asia Pacific market growth over the forecast years.
The fastest-growing segment of the Asia Pacific hemostasis diagnostics market is point of care testing devices because of minimally trained professionals can also effectively use POC instruments for diagnosis.
Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Alere Inc. ,Nihon Kohden Corporation
Rising prevalence of hemophilia and growing geriatric populations are the major driver in the global hemostasis diagnostic market. However, the lack of awareness about hemostasis diseases in emerging countries may hamper the market growth in the Asia Pacific region.
1.Executive Summary |
2. Asia Pacific Hemostasis Diagnostics Market Introduction |
2.1. Asia Pacific Hemostasis Diagnostics Market - Taxonomy |
2.2. Asia Pacific Hemostasis Diagnostics Market - Definitions |
2.2.1.Product Type |
2.2.2.Test Type |
2.2.3.Technology |
2.2.4.End User |
2.2.5.Country |
3. Asia Pacific Hemostasis Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Asia Pacific Hemostasis Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Asia Pacific Hemostasis Diagnostics Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Systems |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Consumables |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Point-of-Care Testing Devices |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Asia Pacific Hemostasis Diagnostics Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Fibrinogen Test |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Activated Clotting Time |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Platelet Function |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Prothrombin Time |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Heparin & Protamine Dose-Response Test For ACT |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Activated Partial Thromboplastin Time |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Anti-Factor Xa |
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Other Coagulation Tests |
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7. Asia Pacific Hemostasis Diagnostics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Optical |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Mechanical |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Electrochemical |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Asia Pacific Hemostasis Diagnostics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Diagnostic Centres |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others (POC) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Asia Pacific Hemostasis Diagnostics Market By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. China |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. India |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Australia and New Zealand (ANZ) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Japan |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Rest of APAC |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.China Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Systems |
10.1.2.Consumables |
10.1.3.Point-of-Care Testing Devices |
10.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Fibrinogen Test |
10.2.2.Activated Clotting Time |
10.2.3.Platelet Function |
10.2.4.Prothrombin Time |
10.2.5.Heparin & Protamine Dose-Response Test For ACT |
10.2.6.Activated Partial Thromboplastin Time |
10.2.7.Anti-Factor Xa |
10.2.8.Other Coagulation Tests |
10.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Optical |
10.3.2.Mechanical |
10.3.3.Electrochemical |
10.3.4.Others |
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Clinics |
10.4.3.Diagnostic Centres |
10.4.4.Others (POC) |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.India Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Systems |
11.1.2.Consumables |
11.1.3.Point-of-Care Testing Devices |
11.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Fibrinogen Test |
11.2.2.Activated Clotting Time |
11.2.3.Platelet Function |
11.2.4.Prothrombin Time |
11.2.5.Heparin & Protamine Dose-Response Test For ACT |
11.2.6.Activated Partial Thromboplastin Time |
11.2.7.Anti-Factor Xa |
11.2.8.Other Coagulation Tests |
11.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Optical |
11.3.2.Mechanical |
11.3.3.Electrochemical |
11.3.4.Others |
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Clinics |
11.4.3.Diagnostic Centres |
11.4.4.Others (POC) |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.Australia and New Zealand (ANZ) Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Systems |
12.1.2.Consumables |
12.1.3.Point-of-Care Testing Devices |
12.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Fibrinogen Test |
12.2.2.Activated Clotting Time |
12.2.3.Platelet Function |
12.2.4.Prothrombin Time |
12.2.5.Heparin & Protamine Dose-Response Test For ACT |
12.2.6.Activated Partial Thromboplastin Time |
12.2.7.Anti-Factor Xa |
12.2.8.Other Coagulation Tests |
12.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Optical |
12.3.2.Mechanical |
12.3.3.Electrochemical |
12.3.4.Others |
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Clinics |
12.4.3.Diagnostic Centres |
12.4.4.Others (POC) |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.Japan Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Systems |
13.1.2.Consumables |
13.1.3.Point-of-Care Testing Devices |
13.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Fibrinogen Test |
13.2.2.Activated Clotting Time |
13.2.3.Platelet Function |
13.2.4.Prothrombin Time |
13.2.5.Heparin & Protamine Dose-Response Test For ACT |
13.2.6.Activated Partial Thromboplastin Time |
13.2.7.Anti-Factor Xa |
13.2.8.Other Coagulation Tests |
13.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Optical |
13.3.2.Mechanical |
13.3.3.Electrochemical |
13.3.4.Others |
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Clinics |
13.4.3.Diagnostic Centres |
13.4.4.Others (POC) |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.Rest of APAC Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Systems |
14.1.2.Consumables |
14.1.3.Point-of-Care Testing Devices |
14.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Fibrinogen Test |
14.2.2.Activated Clotting Time |
14.2.3.Platelet Function |
14.2.4.Prothrombin Time |
14.2.5.Heparin & Protamine Dose-Response Test For ACT |
14.2.6.Activated Partial Thromboplastin Time |
14.2.7.Anti-Factor Xa |
14.2.8.Other Coagulation Tests |
14.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Optical |
14.3.2.Mechanical |
14.3.3.Electrochemical |
14.3.4.Others |
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Clinics |
14.4.3.Diagnostic Centres |
14.4.4.Others (POC) |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Hoffmann-La Roche Ltd. |
15.2.2.Sysmex Corporation |
15.2.3.Abbott Laboratories |
15.2.4.Alere Inc. |
15.2.5.Nihon Kohden Corporation |
15.2.6.Siemens Healthineers |
15.2.7.Danaher Corporation |
16. Research Methodology |
17. Appendix and Abbreviations |